034dkk
-4,0 %
Date:2024-03-01Time:16:59:00Latest report:Q3-2023List:Small CapTicker:PEG
Market Cap:344 mdkkEnterprise Value:355 mdkkNet Sales:- mdkkEarnings:-9,91 mdkkEmployees:0ISIN:DK0061155009

Ratios

10-year key figure history for Pharma Equity turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Pharma Equity with index and moving average MA50 and MA200.

Stockprice:0,34
MA50:0,37
MA200:0,42
Price/MA200:-19,8 %
RSI (14):42,7
Price/MA50:-9,9 %

Description

Pharma Equity Group A/S  is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.

Holding Companies